Skip to main content

Centrexion takes off with drug candidate acquisitions, $17 million new funding – Baltimore Business Journal

By April 22, 2016News
centrexion-therapeurtics-logo

centrexion-therapeurtics-logo

After flying under the radar for two years, Baltimore’s Centrexion Therapeutics ready to make its mark as an emerging pharmaceutical company in the field of pain management.

{iframe}http://www.bizjournals.com/baltimore/blog/cyberbizblog/2016/04/centrexion-takes-off-with-drug-candidate.html?ana=e_bal_rdup&s=newsletter&ed=2016-04-22&u=wjGEy67ABoSnsLErlc5ry0j5hx3&t=1461323588&j=72582712{/iframe}

Leave a Reply

You have successfully subscribed to the newsletter

There was an error while trying to send your request. Please try again.

BioHealth Innovation will use the information you provide on this form to be in touch with you and to provide updates and marketing.